Softwr

AI · head to head

LatchBio vs Orkes

LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Rated
-
Full reviewWebsite
Orkes logo

Orkes

Automation Integration

Commercial Conductor, now the maintainer of the workflow engine Netflix archived

From
Free
Rated
-
Full reviewWebsite

The short version

  • Only Orkes has a free tier, so it costs nothing to try first.
  • Each has a real cost: LatchBio the company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.; Orkes netflix archived the Conductor repository in December 2023 and Orkes took over maintenance, so the large-company backing that justified many original adoptions no longer exists.
  • They diverge on capability: LatchBio covers Agent driven analysis, Orkes covers JSON workflow definitions.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LatchBio and Orkes actually diverge.

Attributes where LatchBio and Orkes differ
AttributeLatchBioOrkes
Starting priceOn requestFree
Free tierNoYes
PlatformsWebLinux, Docker, Kubernetes, Cloud
CategoryAIAutomation Integration

Identical on both: pricing model (quote), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

Only in Orkes

  • JSON workflow definitions
  • Polyglot workers
  • Visual workflow builder
  • AI and LLM tasks
  • Human tasks
  • Event handlers
  • RBAC and secrets
  • Hosted or self-hosted

What people use each for

The jobs each tool is most often brought in to do.

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot Orkes
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot Orkes
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot Orkes
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot Orkes

Orkes

  • A microservices estate that needs orchestration across services written in different languages without a shared SDKnot LatchBio
  • A team already running Conductor OSS that wants a supported distribution now that Netflix has stopped maintaining itnot LatchBio
  • An AI platform composing agent steps, model calls and vector lookups as versioned workflow definitionsnot LatchBio
  • A business process needing human approval steps interleaved with automated service callsnot LatchBio

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus.
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output.
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent.
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow.
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing.

Orkes

  • Netflix archived the Conductor repository in December 2023 and Orkes took over maintenance, so the large-company backing that justified many original adoptions no longer exists.
  • Enterprise pricing is entirely unpublished, and the only free option is explicitly a prototyping sandbox whose limits can change at any time, so there is no supported low-cost entry point.
  • Self-hosting Conductor OSS in production means operating the engine plus its persistence and indexing dependencies, typically Postgres or Cassandra with Elasticsearch, which is a substantial platform commitment.
  • JSON workflow definitions are language agnostic but verbose and awkward to test, and teams accustomed to defining workflows in code find them a step backwards in developer experience.
  • Orkes is a small company whose commercial future is tied to a single open source project it also maintains, which concentrates both vendor and project risk in the same place.

Pricing, plan by plan

LatchBio

On request
  • LatchBio Platform$undefined/year
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Orkes

Free
  • Developer EditionFree
    • All Conductor OSS features plus enterprise capabilities
    • Sandbox for prototyping only
    • Rate limits and resources may change without notice
  • Enterprise$undefined/year
    • Availability SLA up to 99.99%
    • Orkes-hosted or customer-hosted deployment
    • Dedicated technical account manager

Which should you pick?

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.
LatchBio review

Choose Orkes if

  • You need json workflow definitions.
  • You want to start without paying.
  • You work on Linux, Docker, Kubernetes, Cloud.
  • You also want polyglot workers.
Orkes review

Questions people ask

Is LatchBio or Orkes better?
Neither clearly leads. LatchBio starts at On request and Orkes at Free, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LatchBio or Orkes?
Orkes has a free tier; the other does not. Paid plans start at On request for LatchBio and Free for Orkes.
Does LatchBio or Orkes run on more platforms?
LatchBio runs on Web. Orkes runs on Linux, Docker, Kubernetes, Cloud.
Can I use Orkes for free?
Yes. Orkes has a free tier, so you can try it without paying. LatchBio starts at On request.
What is LatchBio best used for?
LatchBio is most often used for a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly, an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files, a wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facility, a research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegated. Of those, a small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quickly and an assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw files are not what Orkes is typically brought in for.
What can LatchBio do that Orkes cannot?
LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals. Orkes covers JSON workflow definitions, Polyglot workers, Visual workflow builder, AI and LLM tasks.

Answered from the vendors’ own pages

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

Orkes: Does Netflix still maintain Conductor?

No. Netflix archived its repository in December 2023. The open source project continues at conductor-oss under Apache 2.0, maintained by Orkes.

LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

Orkes: Is there a free production tier?

No. The Developer Edition is a sandbox that the vendor states is unsuitable for production. Self-hosting Conductor OSS is the free production route.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

Orkes: What does Enterprise cost?

Nothing is published; it is quoted by deployment and support requirements.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Orkes: How does it compare with Temporal?

Conductor uses declarative JSON workflow definitions and external workers; Temporal defines workflows in code. Temporal has the larger community.

Share

Related pages

More on LatchBio

More on Orkes

Keep looking

Other head to heads